Progressive orexin A positive neuron loss in the 6-OHDA mouse model of Parkinson’s disease: a pilot study with validation of an orexin A immunohistochemistry protocol for paraffin-embedded tissue
Brain Research · 2026
DOI: 10.1016/j.brainres.2026.150437 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Brain Research, 2026. Verfasst von Alisha Braun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Health and Biomedical Innovation, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, South Australia 5000, …. Hauptthemen laut MEDLINE: Orexins, Neurons, Immunohistochemistry, Parkinson Disease. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Neurosurgical Research Foundation.
Abstract (Originalsprache)
The aim of this pilot study was to assess a time-dependent loss of orexin neurons in the unilateral intrastriatal 6-OHDA mouse model and to optimise the immunohistochemistry protocol for formalin-fixed, paraffin-embedded mouse brain tissue. A progressive loss of orexin A positive neurons in the lateral hypothalamus was observed in the lesioned side relative to the non-lesioned side. A significant reduction of orexin A positive neurons in the lateral hypothalamus was observed at 4 weeks with further loss at 6-8 weeks post 6-OHDA induction. Orexin neuron loss in the lateral hypothalamus has been reported in post-mortem Parkinson's disease patients and multiple animal studies, particularly in rats; however, evidence in neurotoxic mouse models remains limited. Orexin A positive neuron loss occurred alongside transient motor deficits, olfactory impairments, subtle cognitive changes and gastrointestinal dysfunction. Additionally, an orexin A immunohistochemistry protocol was successfully established for formalin-fixed, paraffin-embedded mouse brain tissue, enabling reproducible and reliable detection of orexin neurons as an alternative to frozen sections. This pilot study serves as a proof of concept that the unilateral intrastriatal 6-OHDA mouse model can successfully recapitulate the progressive loss of orexin A positive neurons and validates this model's suitably for investigating the longitudinal mechanisms of PD symptoms and pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health and Biomedical Innovation, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, South Australia 5000, Australia. Electronic address: alisha.braun@adelaide.edu.au.
- Health and Biomedical Innovation, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, South Australia 5000, Australia. Electronic address: voypy006@mymail.unisa.edu.au.
- Health and Biomedical Innovation, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, South Australia 5000, Australia; Center for Pharmaceutical Innovation, School of Pharmacy an…
Förderung
- Neurosurgical Research Foundation
Zitieren
APA
Braun, A., Vo, P. T., & Bobrovskaya, L. (2026). Progressive orexin A positive neuron loss in the 6-OHDA mouse model of Parkinson’s disease: a pilot study with validation of an orexin A immunohistochemistry protocol for paraffin-embedded tissue. Brain Research. https://doi.org/10.1016/j.brainres.2026.150437
Vancouver
Braun A, Vo PT, Bobrovskaya L. Progressive orexin A positive neuron loss in the 6-OHDA mouse model of Parkinson’s disease: a pilot study with validation of an orexin A immunohistochemistry protocol for paraffin-embedded tissue. Brain Research. 2026. doi:10.1016/j.brainres.2026.150437
BibTeX
@article{Braun2026,
author = {Braun, Alisha and Vo, Phat Tai and Bobrovskaya, Larisa},
title = {Progressive orexin A positive neuron loss in the 6-OHDA mouse model of Parkinson’s disease: a pilot study with validation of an orexin A immunohistochemistry protocol for paraffin-embedded tissue},
journal = {Brain Research},
year = {2026},
doi = {10.1016/j.brainres.2026.150437}
}
EUVIMED